These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 34588386)
21. Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma. Wang N; Luo HJ; Yin GB; Dong CR; Xu M; Chen GG; Liu ZM Clin Dev Immunol; 2013; 2013():589423. PubMed ID: 24288553 [TBL] [Abstract][Full Text] [Related]
22. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma. Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082 [TBL] [Abstract][Full Text] [Related]
23. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer. Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526 [TBL] [Abstract][Full Text] [Related]
24. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer. Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565 [TBL] [Abstract][Full Text] [Related]
25. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients. Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612 [TBL] [Abstract][Full Text] [Related]
26. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter. Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma. Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127 [TBL] [Abstract][Full Text] [Related]
28. Expression of C-X-C motif chemokine receptors 4 and 7 in salivary gland neoplasms. Phattarataratip E; Dhanuthai K Arch Oral Biol; 2017 Nov; 83():136-144. PubMed ID: 28772134 [TBL] [Abstract][Full Text] [Related]
29. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma. Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915 [TBL] [Abstract][Full Text] [Related]
30. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features]. Jiang XL; Zhang H; Chen YL; Peng L Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755 [No Abstract] [Full Text] [Related]
31. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology. Machens A; Dralle H Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749 [TBL] [Abstract][Full Text] [Related]
32. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases. Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024 [TBL] [Abstract][Full Text] [Related]
33. Ursolic acid inhibits proliferation, migration and invasion of human papillary thyroid carcinoma cells via CXCL12/CXCR4/CXCR7 axis through cancer-associated fibroblasts. Cao X; He Q Hum Exp Toxicol; 2022; 41():9603271221111333. PubMed ID: 35786050 [TBL] [Abstract][Full Text] [Related]
34. Capsular Invasion Matters Also in "Papillary Patterned" Tumors: A Study on 121 Cases of Encapsulated Conventional Variant of Papillary Thyroid Carcinoma. Akbulut D; Kuz ED; Kursun N; Dizbay Sak S Endocr Pathol; 2021 Sep; 32(3):357-367. PubMed ID: 33398670 [TBL] [Abstract][Full Text] [Related]
35. Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma. Guang Y; He W; Zhang W; Zhang H; Zhang Y; Wan F Front Endocrinol (Lausanne); 2021; 12():791970. PubMed ID: 34917039 [TBL] [Abstract][Full Text] [Related]
36. Clinicopathological significance of chemokine receptor CXCR4 expression in papillary thyroid carcinoma: a meta-analysis. Wu Z; Cao Y; Jiang X; Li M; Wang G; Yang Y; Lu K Minerva Endocrinol; 2020 Mar; 45(1):43-48. PubMed ID: 29424203 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma. Wu G; Zhou Y; Li T; Guo J; Zhou Z J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894 [TBL] [Abstract][Full Text] [Related]
38. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma. Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026 [TBL] [Abstract][Full Text] [Related]
39. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis. Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191 [TBL] [Abstract][Full Text] [Related]
40. [Role of level VI lymph nodes metastasis in cervical metastasis of patients with papillary thyroid cancer]. Bian X; Chen H; Ye X; Tang PZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):664-8. PubMed ID: 21055244 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]